Ionis Pharmaceuticals
IONS
Last Price
52 Week Range
$23.95 - $86.74
Next Earnings Date
Apr 29 2026 (Estimate)
Next Earnings Date
Apr 29 2026 (Est.)
Last Price
Ionis Pharmaceuticals SEC Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Ionis Pharmaceuticals, Inc. | 8-K | March 9, 2026 | |
Ionis Pharmaceuticals, Inc. | 10-K | February 26, 2026 | |
Ionis Pharmaceuticals, Inc. | 8-K | February 25, 2026 | |
Ionis Pharmaceuticals, Inc. | 8-K | January 12, 2026 | |
Ionis Pharmaceuticals, Inc. | 8-K | January 7, 2026 | |
Ionis Pharmaceuticals, Inc. | 8-K | November 17, 2025 | |
Ionis Pharmaceuticals, Inc. | 8-K | November 10, 2025 | |
Ionis Pharmaceuticals, Inc. | 8-K | October 29, 2025 | |
Ionis Pharmaceuticals, Inc. | 10-Q | October 29, 2025 | |
Ionis Pharmaceuticals, Inc. | 8-K | September 22, 2025 | |
Ionis Pharmaceuticals, Inc. | 8-K | September 2, 2025 | |
Ionis Pharmaceuticals, Inc. | 8-K | August 21, 2025 | |
Ionis Pharmaceuticals, Inc. | 8-K | July 30, 2025 | |
Ionis Pharmaceuticals, Inc. | 10-Q | July 30, 2025 | |
Ionis Pharmaceuticals, Inc. | 8-K | June 12, 2025 | |
Ionis Pharmaceuticals, Inc. | 8-K | June 10, 2025 | |
Ionis Pharmaceuticals, Inc. | 8-K | May 19, 2025 | |
Ionis Pharmaceuticals, Inc. | 8-K | April 30, 2025 | |
Ionis Pharmaceuticals, Inc. | 10-Q | April 30, 2025 | |
Ionis Pharmaceuticals, Inc. | DEF 14A | April 25, 2025 | |
Ionis Pharmaceuticals, Inc. | DEFA14A | April 25, 2025 | |
Ionis Pharmaceuticals, Inc. | ARS | April 25, 2025 | |
Ionis Pharmaceuticals, Inc. | 8-K | March 12, 2025 | |
Ionis Pharmaceuticals, Inc. | 8-K | February 19, 2025 | |
Ionis Pharmaceuticals, Inc. | 10-K | February 19, 2025 | |
Ionis Pharmaceuticals, Inc. | 8-K | December 20, 2024 | |
Ionis Pharmaceuticals, Inc. | 10-Q | November 6, 2024 | |
Ionis Pharmaceuticals, Inc. | 8-K | November 6, 2024 | |
Ionis Pharmaceuticals, Inc. | 8-K | September 12, 2024 | |
Ionis Pharmaceuticals, Inc. | 8-K | September 9, 2024 |
Load More...
Gainify
Features
Platform
Resources
Learn
Socials
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
© 2026 Gainify. All rights reserved.